Dissecting cancer serum protein profiles using antibody arrays

Methods in Molecular Biology

Volumn 428, Issue , 2007, Pages 263-287

  Sanchez Carbayo, Marta ^a  

^a NONE

Author keywords

Antibody arrays; Direct labeling; Protein profiling; Serum

Indexed keywords

ANTIBODY; FLUORESCENT DYE; TUMOR PROTEIN;

ARTICLE; BLOOD; HUMAN; IMMUNOASSAY; IMMUNOLOGY; METHODOLOGY; NEOPLASM; PROTEIN MICROARRAY; PROTEOMICS;

ANTIBODIES; FLUORESCENT DYES; HUMANS; IMMUNOASSAY; NEOPLASM PROTEINS; NEOPLASMS; PROTEIN ARRAY ANALYSIS; PROTEOMICS;

EID: 40549102745     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (34)

1. Haab BB, Dunham MJ, Brown PO. (2001). Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions. Genome Biol. 2(2): research 0004.1-0004.13.
2. Chan SM, Ermann J, Su L, Fathman CG, Utz PJ. (2004). Protein microarrays for multiplex analysis of signal transduction pathways. Nat Med. 10, 1390-6.
3. Sanchez-Carbayo M. (2006). Antibody arrays: technical considerations and clinical applications in cancer. Clin Chem, 52, 1651-9.
4. Barry R, Diggle T, Terrett J, Soloviev M. (2003). Competitive assay formats for high-throughput affinity arrays. J Biomol Screen. 8, 257-63.
5. Pang S, Smith J, Onley D, Reeve J, Walker M, Foy C (2005). A comparability study of the emerging protein array platforms with established ELISA procedures. J Immunol Meth. 302, 1-13.
6. Lash GE, Scaifo PJ, Innes BA, Otun HA, Robson SC, Searle RF, Bulmer JN. (2006). Comparison of three multiplex cytokine analysis systems: Luminex, SearchLight and FAST Quant. J Immunol Meth. 309, 205-8.
7. de Jager W, Rijkers GT. (2006). Solid-phase and bead-based cytokine immuno-assay: a comparison. Methods 38, 294-303.
8. Waterboer T, Sehr P, Pawlita M, (2006). Suppression of non-specific binding in serological Luminex assays. J Immunol Methods. 309, 200-4.
9. Kingsmore SF. (2006). Multiplexed protein measurement: technologies and applications of protein and antibody arrays. Nat Rev Drug Discov. 5, 310-21.
10. Wang X, Yu J, Sreekumar A, Varambally S, Shen R, Giacherio D, Mehra R, Montie JE, Pienta KJ, Sanda MG, Kantoff PW, Rubin MA, Wei JT, Ghosh D, Chinnaiyan AM. (2005). Autoantibody signatures in prostate cancer. N Engl J Med. 353,1224-35.
11. Anderson KS, LaBaer J. (2005). The sentinel within: exploiting the immune system for cancer biomarkers. J Roteome Res. 4, 1123-33.
12. Petricoin EF III, Bichsel VE, Calvert VS, Espina V, Winters M, Young L, Belluco C, Trock BJ, Lippman M, Fishman DA, Sgroi DC, Munson PJ, Esserman I.J, Liotta LA. (2005). Mapping molecular networks using proteomics: a vision for patient-tailored combination therapy. J Clin Oncol. 23, 3614-21.
13. Angenendt P, Glokler J, Murphy D, Lehrach H, Cahill. DJ. (2002). Toward, optimized antibody microarrays: a comparison of current microarray support materials. Anal Biochem, 309, 253-60.
14. Espina V, Woodhouse EC, Wulfkuhle J, Asmussen HD, Petricoin EF III, Liotta LA. (2004). Protein microarray detection strategies: focus on direct detection technologies. J Immunol. Methods. 290, 121-33.
15. Levit-Binnun N, Lindner AB, Zik O, Eshhar Z, Moses E. (2003). Quantitative detection of protein arrays. Anal Chem, 75, 1436-41.
16. Pawlak B, Gordon R. (2005). Density estimation for positron emission tomography. Technol Cancer Res Treat. 4, 131-42.
17. Schweitzer B, Roberts S, Grimwade B, Shao W, Wang M, Fu Q, Shu Q, Laroche I, Zhou Z, Tchernev VT, Christiansen J, Velleca M, Kingsmore SF. (2002). Multiplexed protein profiling on microarrays by rolling-circle amplification. Nat Biotechnol. 20, 359-65.
18. Pasternack RF, Collings PJ. (1995). Resonance light scattering: a new technique for studying chromophore aggregation. Science. 269, 935-9.
19. Stich N, Gandhum. A, Matyushin V, Raats J, Mayer C, Alguel Y, Schalkhammer T. (2002). Phage display antibody-based proteomic device using resonance-enhanced detection. J Nanosci Nanotechnol. 2, 375-81.
20. Lindskog M, Rockberg J, Uhlen M, Sterky F. (2005). Selection of protein epitopes for antibody production. Biotechniques. 38, 723-7.
21. Miller JC, Zhou. H, Kwekel J, Cavallo R, Burke J, Butler EB, Teh BS, Haab BB. (2003). Antibody microarray profiling of human prostate cancer sera: antibody screening and identification of potential biomarkers. Proteomics. 3, 56-63.
22. Zhou H, Bouwman K, Schotanus M, Verweij C, Marrero JA, Dillon D, Costa J, Lizardi P, Haab BB. (2004). Two-color, rolling-circle amplification on antibody microarrays for sensitive, multiplexed serum-protein measurements. Genome Biol. 5, R28.
23. Shao W, Zhou. Z, Laroche I, Lu. H, Zong Q, Patel DD, Kingsmore S, Piccoli SP. (2003). Optimization of rolling-circle amplified protein microarrays for multiplexed protein profiling. J Biomed Biotechnol. 5, 299-307.
24. Sanchez-Carbayo M, Socci ND, Lozano JJ, Haab BB, Cordon-Cardo C (2006). Rofiling bladder cancer using targeted antibody arrays. Am J Pathol. 168, 93-103.
25. Saviranta P, Okon R, Brinker A, Warashina M, Eppinger J, Geierstanger BH. (2004). Evaluating sandwich immunoassays in microarray format in terms of the ambient analyte regime. Clin Chem, 50, 1907-20.
26. Huang R, Lin Y, Shi Q, Flowers L, Ramachandran S, Horowitz IR, Parthasarathy S, Huang RP. (2004). Enhanced protein profiling arrays with ELISA-based amplification for high-throughput molecular changes of tumor patients' plasma. Clin Cancer Res. 10, 598-609.
27. Varnum SM, Woodbury RL, Zangar RC (2004). A protein microarray ELISA for screening biological fluids. Methods Mol Biol. 264, 161.-72.
28. Gembitsky DS, Lawlor K, Jacovina A, Yaneva M, Tempst P. (2004). A prototype antibody microarray platform to monitor changes in protein tyrosine phosphorylation. Mol Cell Proteomics. 3, 1102-18.
29. Janzi M, Odling J, Pan-Hammarstrom Q, Sundberg M, Lundeberg J, Uhlen M, Hammarstrom L, Nilsson P. (2005). Serum, microarrays for large scale screening of protein levels. Mol Cell Roteomics. 4, 1942-7.
30. MacBeath G, Schreiber SL. (2000). Rinting proteins as microarrays for highthroughput function determination. Science. 289, 1760-3.
31. Knezevic V, Leethanakul C, Bichsel VE, Worth JM, Prabhu VV, Gutkind JS, Liotta LA, Munson PJ, Petricoin EF 3rd, Krizman DB. (2001). Proteomic profiling of the cancer microenvironment by antibody arrays. Roteomics. 1, 1271-8.
32. Arenkov P, Kukhtin A, Gemmell A, Voloshchuk S, Chupeeva V, Mirzabekov A. (2000). Potein microchips: use for immunoassay and enzymatic reactions. Anal Biochem. 278, 123-31
33. Rai AJ, Gelfand CA, Haywood BC, Warunek DJ, Yi J, Schuchard MD, Mehigh RJ, Cockrill SL, Scott GB, Tammen H, Schulz-Knappe P, Speicher DW, Vitzthum F, Haab BB, Siest G, Chan DW. (2005). HUPO Plasma Roteome Roject specimen collection and handling: towards the standardization of parameters for plasma proteome samples. Proteomics. 5, 3262-77.
34. States DJ, Omenn GS, Blackwell TW, Fermin D, Eng J, Speicher DW, Hanash SM. (2006). Challenges in deriving high-confidence protein identifications from data gathered by a, HUPO plasma proteome collaborative study. Nat Biotechnol. 24, 333-8. 35. Uhlen M, Bjorling E, Agaton C, Szigyarto CA, Amini B, Andersen E, Andersson AC, Angelidou P, Asplund A, Asplund C, Berglund L, Bergstrom K, Bramer H, Cerjan D, Ekstrom M, Elobeid A, Eriksson C, Fagerberg L, Falk R, Fall J, Forsberg M, Bjorklund MG, Gumbel K, Halimi A, Hallin I, Hamsten C, Hansson M, Hedhammar M, Hercules G, Kampf C, Larsson K, Lindskog M, Lodewyckx W, Lund J, Lundeberg J, Magnusson K, Malm E, Nilsson P, Odling J, Oksvold P, Olsson I, Oster E, Ottosson J, Paavilainen L, Persson A, Rimini R, Rockberg J, Runeson M, Sivertsson A, Skollermo A, Steen J, Stenvall M, Sterky F, Stromberg S, Sundberg M, Tegel H, Tourle S, Wahlund E, Walden A, Wan J, Wernerus H, Westberg J, Wester K, Wrethagen U, Xu LL, Hober S, Pon ten F. (2005). A human protein atlas for normal and cancer tissues based on antibody proteomics. Mol Cell Roteomics. 4, 1920-32.